Lexicon Pharmaceuticals LXRX Income Tax Reconciliation Change In Enacted Tax Rate
Income Tax Reconciliation Change In Enacted Tax Rate at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's income tax reconciliation change in enacted tax rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's income tax reconciliation change in enacted tax rate?
- Lexicon Pharmaceuticals (LXRX) reported income tax reconciliation change in enacted tax rate of $730.5K in Q4 2024.
- How has Lexicon Pharmaceuticals's income tax reconciliation change in enacted tax rate changed year-over-year?
- Lexicon Pharmaceuticals's income tax reconciliation change in enacted tax rate increased by 161.9% year-over-year, from -$1.18M to $730.5K.
- What does income tax reconciliation change in enacted tax rate mean?
- This metric represents the impact on the income tax provision resulting from changes in statutory tax rates enacted during the reporting period. It highlights the sensitivity of the company's deferred tax assets and liabilities to legislative shifts in tax policy. Investors use this to assess potential volatility in future tax expenses due to external regulatory changes.